Figure1a:
Cumulative percent change in FEV1 for increasing amounts of bronchodilator for patients with asthma enrolled in SARP I-II.
1b: Maximal lung function following bronchodilator in children with asthma enrolled in SARP I-II.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.